CLDN3 and breast cancer: In addition, low levels of claudin-3, -4, and -7 is a hallmark of a subgroup of mainly triple-negative (no amplification of HER2 and negative for estrogen and progesterone receptors) breast cancers with mesenchymal and cancer stem cell-like features [24, 25].